Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Xeris Pharmaceuticals
Xeris Pharmaceuticals
(XERS)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Gvoke
Glucagon
2019-09-10
2036-2039
Hypotension
,
Diabetes mellitus
,
Cardiogenic shock
,
Anaphylaxis
,
Hypoglycemia
,
Bradycardia
Keveyis
Dichlorphenamide
1982-01-01
Glaucoma
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Glucagon
congenital hyperinsulinism
,
nesidioblastosis
,
diabetes mellitus
,
hyperinsulinism
,
hypoglycemia
,
type 1 diabetes mellitus
Ademetionine
hypoglycemia
,
congenital hyperinsulinism
,
nesidioblastosis
Sodium chloride
hypoglycemia
,
congenital hyperinsulinism
,
nesidioblastosis
,
hyperinsulinism
Viaject
type 1 diabetes mellitus
,
hypoglycemia
,
diabetes mellitus
Pram9
diabetes mellitus
,
type 1 diabetes mellitus
Pancreatin
type 1 diabetes mellitus
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use